Search
Feed aggregator
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study 7/8/2024
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo 7/8/2024
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling 7/8/2024
Beyond GLP-1s: The Next Obesity Treatments
Beyond GLP-1s: The Next Obesity Treatments 7/8/2024
Drug Developers Tap the Immune System to Supercharge ADCs
Drug Developers Tap the Immune System to Supercharge ADCs 7/8/2024
Patient Assistance Programs: A Source of Real-World Data?
Patient Assistance Programs: A Source of Real-World Data? 7/8/2024
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids 5/8/2024
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More 5/8/2024
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy 5/8/2024
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters 5/8/2024
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient 5/8/2024
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm 5/8/2024
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird 5/8/2024
Generative AI Finds Its Footing in Drug Development
Generative AI Finds Its Footing in Drug Development 5/8/2024
BMS, J&J Losses Not the End of IRA Legal Battle
BMS, J&J Losses Not the End of IRA Legal Battle 5/8/2024
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs 4/8/2024
BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win
BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win 4/8/2024
ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint
ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint 4/8/2024
5 Successful Phase III Oncology Trials in Q1
5 Successful Phase III Oncology Trials in Q1 4/8/2024
The Next Wave of ADCs Could Treat Evasive Solid Tumors
The Next Wave of ADCs Could Treat Evasive Solid Tumors 4/8/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target